Characterization and quality control of recombinant adenovirus vectors for gene therapy.
Highly purified recombinant adenovirus undergoes routine quality controls for identity, potency and purity prior to its use as a gene therapy vector. Quantitative characterization of infectivity is measurable by the expression of the DNA binding protein, an early adenoviral protein, in an immunofluorescence bioassay on permissive cells as a potency determinant. The specific particle count, a key quality indicator, is the total number of intact particles present compared to the number of infectious units. Electron microscopic analysis using negative staining gives a qualitative biophysical analysis of the particles eluted from anion-exchange HPLC. One purity assessment is accomplished via the documented presence and relative ratios of component adenoviral proteins as well as potential contaminants by reversed-phase HPLC of the intact virus followed by protein peak identification using MALDI-TOF mass spectrometry and subsequent data mining. Verification of the viral genome is performed and expression of the transgene is evaluated in in vitro systems for identity. Production lots are also evaluated for replication-competent adenovirus prior to human use. For adenovirus carrying the human IL-2 transgene, quantitative IL-2 expression is demonstrated by ELISA and cytokine potency by cytotoxic T lymphocyte assay following infection of permissive cells. Both quantitative and qualitative analyses show good batch to batch reproducibility under routine test conditions using validated methods.
Roitsch
C
C
Department of Quality Control, TRANSGENE, Strasbourg, France. roitsch@transgene.fr
Achstetter
T
T
Benchaibi
M
M
Bonfils
E
E
Cauet
G
G
Gloeckler
R
R
L'h te
H
H
Keppi
E
E
Nguyen
M
M
Spehner
D
D
Van Dorsselaer
A
A
Malarme
D
D
D000256:Adenoviridae / Q000235:genetics* / Q000472:pathogenicity; D000595:Amino Acid Sequence; D000818:Animals; D015139:Blotting, Southern; D002851:Chromatography, High Pressure Liquid; D002852:Chromatography, Ion Exchange; D004797:Enzyme-Linked Immunosorbent Assay; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000737:chemistry*; D006801:Humans; D007376:Interleukin-2 / Q000276:immunology; D051379:Mice; D008854:Microscopy, Electron; D008969:Molecular Sequence Data; D011786:Quality Control; D011995:Recombination, Genetic; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019076:Transgenes
D007376:Interleukin-2